Executive - Quality Control

You will be responsible for performing chemical and instrumentation analysis on various materials including in-process, raw materials, packing materials, intermediates, and finished products. Your primary goal will be to ensure compliance with dispatch timelines as per the monthly schedule provided by PPL. Your duties will include conducting instrumentation analysis using ICP-MS and LC-MS for the mentioned materials to meet dispatch timelines. Additionally, you will be involved in analytical method developments, validations, transfers, and verifications using ICP-MS and LC-MS/MS. You will be required to prepare and review protocols, worksheets, and reports for method developments, validations, verifications, and transfers. Allotting work to chemists within the section, calibrating instruments, maintaining documentation online, and ensuring minimum stock levels for various materials and standards will also be part of your responsibilities. Monitoring and reviewing analytical data, calibration data, and qualification data, as well as ensuring instruments are calibrated and maintained in working condition, will be crucial tasks. You will also play a key role in reducing lab incidences, implementing CAPA, and maintaining safe working conditions. Collaboration with QA, Production, PPIC, Warehouse, and TSD for smooth dispatches, as well as training employees on GLP/GMP and coordinating with external laboratories, will be essential aspects of your role. Your commitment to data integrity, timely analysis and release of batches, cost control, and adherence to safety practices will contribute to the overall success of the team. This position requires a Bachelor's degree and offers an opportunity to work with Piramal Pharma Solutions (PPS), a Contract Development and Manufacturing Organization (CDMO) known for its end-to-end development and manufacturing solutions across the drug life cycle. PPAs serves customers globally and provides a wide range of services, making it a preferred partner for innovators and generic companies.,